Invion Limited (IVX.AX)

AUD 0.26

(-7.14%)

EBITDA Summary of Invion Limited

Invion Limited's latest annual EBITDA in 2024 was -4.57 Million AUD , down -373.58% from previous year.
Invion Limited's latest quarterly EBITDA in 2024 FY was N/A , down -403.56% from previous quarter.
Invion Limited reported an annual EBITDA of -965.36 Thousand AUD in 2023, up 49.17% from previous year.
Invion Limited reported an annual EBITDA of -1.89 Million AUD in 2022, down -46.7% from previous year.
Invion Limited reported a quarterly EBITDA of -350.29 Thousand AUD for 2024 Q2, down 0.0% from previous quarter.
Invion Limited reported a quarterly EBITDA of -4.51 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Invion Limited (2024 - 2009)

Historical Annual EBITDA of Invion Limited (2024 - 2009)

Year	EBITDA	EBITDA Growth
2024	-4.57 Million AUD	-373.58%
2023	-965.36 Thousand AUD	49.17%
2022	-1.89 Million AUD	-46.7%
2021	-1.29 Million AUD	-72.93%
2020	-748.55 Thousand AUD	66.1%
2019	-2.2 Million AUD	-705.43%
2018	-2.92 Million AUD	143.39%
2017	-840.41 Thousand AUD	82.78%
2016	-4.6 Million AUD	55.92%
2015	-13.49 Million AUD	-95.1%
2014	-6.32 Million AUD	-38.14%
2013	-5.67 Million AUD	9.49%
2012	-7.22 Million AUD	61.77%
2011	-11.86 Million AUD	11.29%
2010	-13.38 Million AUD	0.0%
2009	- AUD	0.0%

Year	EBITDA	EBITDA Growth
2024 FY	- AUD	-403.56%
2024 Q2	-350.29 Thousand AUD	0.0%
2024 Q4	-4.51 Million AUD	0.0%
2023 Q2	-504.44 Thousand AUD	0.0%
2023 Q4	-460.92 Thousand AUD	0.0%
2023 FY	- AUD	49.17%
2022 Q4	-938.11 Thousand AUD	0.0%
2022 Q2	-960.9 Thousand AUD	0.0%
2022 FY	- AUD	-46.7%
2021 Q4	-492.6 Thousand AUD	0.0%
2021 Q2	-801.87 Thousand AUD	0.0%
2021 FY	- AUD	-72.93%
2020 Q4	296.45 Thousand AUD	0.0%
2020 Q2	-1.04 Million AUD	0.0%
2020 FY	- AUD	66.1%
2019 Q4	70.79 Thousand AUD	0.0%
2019 Q2	-796.5 Thousand AUD	0.0%
2019 FY	- AUD	-705.43%
2018 Q2	-520.89 Thousand AUD	0.0%
2018 FY	- AUD	143.39%
2017 Q2	-485.99 Thousand AUD	0.0%
2017 Q4	-354.42 Thousand AUD	0.0%
2017 FY	- AUD	82.78%
2016 FY	- AUD	55.92%
2016 Q2	-3.13 Million AUD	0.0%
2016 Q4	-1.61 Million AUD	0.0%
2015 FY	- AUD	-95.1%
2015 Q4	-7.31 Million AUD	0.0%
2015 Q2	-6.17 Million AUD	0.0%
2014 Q2	-2.7 Million AUD	0.0%
2014 Q4	-3.62 Million AUD	0.0%
2014 FY	- AUD	-38.14%
2013 Q2	-2.84 Million AUD	-148.79%
2013 Q1	-1.14 Million AUD	0.0%
2013 Q4	-2.38 Million AUD	-126.59%
2013 Q3	-1.05 Million AUD	63.05%
2013 FY	- AUD	9.49%
2012 Q2	-1.14 Million AUD	61.49%
2012 Q3	-1.14 Million AUD	0.0%
2012 Q4	-1.14 Million AUD	0.0%
2012 FY	- AUD	61.77%
2012 Q1	-2.96 Million AUD	0.0%
2011 Q1	-3.34 Million AUD	0.0%
2011 Q4	-2.96 Million AUD	0.0%
2011 FY	- AUD	11.29%
2011 Q2	-2.96 Million AUD	11.29%
2011 Q3	-2.96 Million AUD	0.0%
2010 FY	- AUD	0.0%
2010 Q1	- AUD	0.0%
2010 Q2	-3.34 Million AUD	0.0%
2010 Q4	-3.34 Million AUD	0.0%
2010 Q3	-3.34 Million AUD	0.0%
2009 Q4	- AUD	0.0%
2009 Q2	- AUD	0.0%
2009 FY	- AUD	0.0%
2009 Q3	- AUD	0.0%

Peer EBITDA Comparison of Invion Limited

Name	EBITDA	EBITDA Difference
Althea Group Holdings Limited	-28.56 Million AUD	83.993%
Cann Group Limited	-35.53 Million AUD	87.135%
ECS Botanics Holdings Ltd	3.22 Million AUD	241.615%
Ecofibre Limited	-38.34 Million AUD	88.077%
Elixinol Wellness Limited	-6.8 Million AUD	32.828%
Hygrovest Limited	-1.1 Million AUD	-314.483%
IDT Australia Limited	-5.13 Million AUD	10.934%
Little Green Pharma Ltd	-4.64 Million AUD	1.541%
Live Verdure Ltd	-12.51 Million AUD	63.46%
Medical Developments International Limited	-29.44 Million AUD	84.474%
Vitura Health Limited	7.07 Million AUD	164.607%
Vita Life Sciences Limited	13.09 Million AUD	134.904%